196 related articles for article (PubMed ID: 37529677)
21. Lessons from free energy simulations of delta-opioid receptor homodimers involving the fourth transmembrane helix.
Provasi D; Johnston JM; Filizola M
Biochemistry; 2010 Aug; 49(31):6771-6. PubMed ID: 20617813
[TBL] [Abstract][Full Text] [Related]
22. Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding.
Goricanec D; Stehle R; Egloff P; Grigoriu S; Plückthun A; Wagner G; Hagn F
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3629-38. PubMed ID: 27298341
[TBL] [Abstract][Full Text] [Related]
23. Molecular modeling of salsolinol, a full G
Berríos-Cárcamo P; Rivera-Meza M; Herrera-Marschitz M; Zapata-Torres G
Chem Biol Drug Des; 2019 Aug; 94(2):1467-1477. PubMed ID: 30920734
[TBL] [Abstract][Full Text] [Related]
24. The opioid system in the gastrointestinal tract.
Sternini C; Patierno S; Selmer IS; Kirchgessner A
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():3-16. PubMed ID: 15357847
[TBL] [Abstract][Full Text] [Related]
25. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
Elife; 2020 Feb; 9():. PubMed ID: 32096468
[TBL] [Abstract][Full Text] [Related]
26. Galphai is not required for chemotaxis mediated by Gi-coupled receptors.
Neptune ER; Iiri T; Bourne HR
J Biol Chem; 1999 Jan; 274(5):2824-8. PubMed ID: 9915816
[TBL] [Abstract][Full Text] [Related]
27. Regulation of GDP and GTP binding in cardiac sarcolemma by muscarinic receptor agonists.
Quist E
Mol Pharmacol; 1992 Jan; 41(1):168-76. PubMed ID: 1732718
[TBL] [Abstract][Full Text] [Related]
28. Immunoprecipitation of alpha 2a-adrenergic receptor-GTP-binding protein complexes using GTP-binding protein selective antisera. Changes in receptor/GTP-binding protein interaction following agonist binding.
Okuma Y; Reisine T
J Biol Chem; 1992 Jul; 267(21):14826-31. PubMed ID: 1353077
[TBL] [Abstract][Full Text] [Related]
29. Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors.
Golebiewska U; Johnston JM; Devi L; Filizola M; Scarlata S
Biochemistry; 2011 Apr; 50(14):2829-37. PubMed ID: 21361347
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution of rat brain mu opioid receptors with purified guanine nucleotide-binding regulatory proteins, Gi and Go.
Ueda H; Harada H; Nozaki M; Katada T; Ui M; Satoh M; Takagi H
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):7013-7. PubMed ID: 2842801
[TBL] [Abstract][Full Text] [Related]
31. The mechanism of ligand-induced activation or inhibition of μ- and κ-opioid receptors.
Yuan S; Palczewski K; Peng Q; Kolinski M; Vogel H; Filipek S
Angew Chem Int Ed Engl; 2015 Jun; 54(26):7560-3. PubMed ID: 25968837
[TBL] [Abstract][Full Text] [Related]
32. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
33. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
34. Propagation of conformational changes during μ-opioid receptor activation.
Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
[TBL] [Abstract][Full Text] [Related]
35. Gα
Kossoń P; Dyniewicz J; Lipiński PFJ; Matalińska J; Misicka A; Bojarski AJ; Mordalski S
Pharmacol Rep; 2023 Apr; 75(2):465-473. PubMed ID: 36840824
[TBL] [Abstract][Full Text] [Related]
36. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
Wang D; Chen T; Zhou X; Couture R; Hong Y
Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
[TBL] [Abstract][Full Text] [Related]
37. The nucleotide exchange factor Ric-8A is a chaperone for the conformationally dynamic nucleotide-free state of Gαi1.
Thomas CJ; Briknarová K; Hilmer JK; Movahed N; Bothner B; Sumida JP; Tall GG; Sprang SR
PLoS One; 2011; 6(8):e23197. PubMed ID: 21853086
[TBL] [Abstract][Full Text] [Related]
38. Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization.
Hong MH; Xu C; Wang YJ; Ji JL; Tao YM; Xu XJ; Chen J; Xie X; Chi ZQ; Liu JG
J Neurochem; 2009 Jan; 108(1):102-14. PubMed ID: 19014372
[TBL] [Abstract][Full Text] [Related]
39. Adenosine A1( )receptors are selectively coupled to Gα(i-3) in postmortem human brain cortex: Guanosine-5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTPγS) binding/immunoprecipitation study.
Odagaki Y; Kinoshita M; Ota T; Javier Meana J; Callado LF; García-Sevilla JA
Eur J Pharmacol; 2015 Oct; 764():592-598. PubMed ID: 26213104
[TBL] [Abstract][Full Text] [Related]
40. Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.
Remmers AE; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1999 Feb; 288(2):827-33. PubMed ID: 9918595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
